亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies

医学 肥胖 环境卫生 体质指数 代谢综合征 糖尿病 人体测量学 生理学 梅德林 正常重量 体重 流行病学 人口学 横断面研究
作者
Yse D'Ailhaud De Brisis,Lakshya Jain,James E. Bennett,Bin Zhou,Edward W. Gregg,Ana Barradas‐Pires,Rodrigo Martin Carrillo-Larco,Agnese Galeazzi,Fulvio Deo,Olivia N O'Driscoll,范晔峰,Nayu Ikeda,Hsien-Ho Lin,Gretchen Anna Stevens,Wichai Aekplakon,Tuija Jääskeläinen,Pekka Jousilahti,Niina E. Kaartinen,Young‐Ho Khang,Kamlesh Khunti
出处
期刊:The Lancet [Elsevier BV]
卷期号:408 (10552): 325-347 被引量:3
标识
DOI:10.1016/s0140-6736(26)00758-0
摘要

Summary Background Effective treatments are available for obesity and for hypertension and hypercholesterolaemia, which mediate the cardiovascular and renal effects of obesity. Our aim was to compare blood pressure, cholesterol, and the use of antihypertensive and lipid-lowering medicines in people with obesity and normal weight and assess whether the BMI-associated excess risk has diminished. Methods Our primary outcomes were mean systolic blood pressure (SBP), non-HDL cholesterol and HDL cholesterol, and the proportion of the participants who used antihypertensive and lipid-lowering medicines. We used data from 110 health surveys conducted from 1990 to 2024 with 978 425 participants aged 20–79 years sampled from national populations of seven countries: Japan, South Korea, Taiwan, Thailand, Finland, England, and the USA. We used graphical presentation and trend analysis to evaluate changes over time in these outcomes in participants in the normal BMI range (20·0 to <25·0 kg/m2), and changes in the difference between participants with obesity (separately for class I obesity [30·0 to <35·0 kg/m2] and class II and III obesity [BMI ≥35·0 kg/m2]) or overweight (25·0 to <30·0 kg/m2) and those in the normal BMI range. Findings Mean non-HDL cholesterol and SBP declined over time, especially among those older than 40 years, with the notable exception of some sex–age groups in Thailand. When pooled across all countries, age groups, and obesity and overweight BMI ranges, the difference in mean non-HDL cholesterol with normal BMI became smaller by –0·05 mmol/L per decade (95% CI –0·07 to –0·03) for females and –0·07 mmol/L per decade (–0·09 to –0·05) for males. For SBP, the pooled estimate of change in the difference with normal BMI across all countries, age groups, and obesity and overweight BMI ranges was –0·7 mmHg per decade (95% CI –1·0 to –0·4) for females and –0·6 mmHg per decade (–0·9 to –0·4) for males. The declines were larger in individuals with obesity, especially class II and III obesity, than in normal BMI, leading to a convergence of these risk factors between obesity and normal BMI in people older than 40 years. As a result of these trends, in England, the USA, Thailand, South Korea, and Japan, older people with obesity often became indistinguishable from, or better off than, those with normal BMI in terms of non-HDL cholesterol and SBP. These trends accompanied a larger increase in the use of lipid-lowering and antihypertensive medicines in middle-aged and older people with obesity than in those with normal BMI. The pooled estimate for the increase in difference in lipid-lowering medicines compared with normal BMI across all countries, age groups, and obesity and overweight BMI ranges was 1·5 percentage points per decade (1·0–2·1) for females and 1·6 percentage points per decade (1·0–2·2) for males. For antihypertensive medicines, the pooled estimate was 0·7 percentage points per decade (0·3–1·0) for females and 2·0 percentage points per decade (1·3–2·8) for males. Mean HDL cholesterol increased more in people with normal BMI than those with obesity, leading to a divergence. For people younger than 40 years, there has been little change in the gap between those with obesity or overweight and those with normal BMI; young adults were rarely treated for high cholesterol or blood pressure regardless of their BMI. Interpretation In industrialised countries, blood pressure and non-HDL cholesterol in older adults with obesity are increasingly similar to those with normal BMI, with higher use of antihypertensive and lipid-lowering medicines a possible driver of this convergence. There is nonetheless heterogeneity across countries in the extent of convergence. Young adults with obesity remain metabolically at higher risk than their counterparts with normal weight. Funding UK Medical Research Council and UK Research and Innovation (Innovate UK).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
飞飞飞完成签到,获得积分10
1秒前
凤飞完成签到,获得积分10
2秒前
仟111完成签到 ,获得积分10
3秒前
EricSai发布了新的文献求助10
3秒前
4秒前
LL完成签到 ,获得积分10
7秒前
7秒前
amiee完成签到,获得积分10
7秒前
迷人悒发布了新的文献求助10
8秒前
迷人悒发布了新的文献求助10
8秒前
迷人悒发布了新的文献求助10
8秒前
迷人悒发布了新的文献求助10
9秒前
迷人悒发布了新的文献求助10
9秒前
迷人悒发布了新的文献求助10
9秒前
Jasper的应助被EricSai采纳,获得10
9秒前
大个的应助被Tuffyffy采纳,获得10
10秒前
molihuakai的应助被karstbing采纳,获得50
10秒前
酷波er的应助被LLL采纳,获得10
11秒前
11秒前
13秒前
顾矜的应助被搞怪巨人采纳,获得10
15秒前
hhh发布了新的文献求助10
15秒前
Jerry发布了新的文献求助10
16秒前
pluvia完成签到,获得积分10
16秒前
平淡的翅膀完成签到 ,获得积分10
18秒前
所所的应助被asr采纳,获得10
18秒前
萧雨墨发布了新的文献求助10
21秒前
完美世界的应助被Jerry采纳,获得10
21秒前
21秒前
一葵完成签到 ,获得积分10
22秒前
单薄的誉完成签到,获得积分10
22秒前
CipherSage的应助被花海采纳,获得10
23秒前
24秒前
盼月来完成签到 ,获得积分10
24秒前
uri完成签到 ,获得积分10
24秒前
wwwww完成签到,获得积分10
25秒前
26秒前
白芷完成签到 ,获得积分10
27秒前
28秒前
Log发布了新的文献求助10
28秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190026
求助须知:如何正确求助?哪些是违规求助? 9577160
关于积分的说明 21851766
捐赠科研通 7788109
什么是DOI,文献DOI怎么找? 3435873
关于科研通互助平台的介绍 2559910
邀请新用户注册赠送积分活动 2482761